All In Biotech

Free tool

FAERS Monitor: Nipride Rtu In Sodium Chloride 0.9%

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209387 or its brand name (Nipride Rtu In Sodium Chloride 0.9%, Sodium Nitroprusside). Reports on generic versions are filed under their own applications.

Reports

387

Serious

360

93% of reports

Hospitalization

175

Death reported

85

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • renal failure74
  • pain62
  • injury59
  • anxiety58
  • unevaluable event55
  • drug ineffective53
  • fear53
  • toxicity to various agents49
  • renal injury44
  • emotional distress43
  • anhedonia41
  • renal impairment38
  • stress38
  • hypotension34
  • multi-organ failure32

Reports by year received

View as table
YearReports
20048
20056
200610
20076
20086
20098
201010
201175
20129
20133
20141
201516
20168
201715
201811
201920
202019
202129
202227
202327
202431
202519
202623

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,772 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
fearSignal53107.383.55,472
multi-organ failureSignal32100.772.23,057
anhedoniaSignal4184.963.63,316
renal injurySignal4480.661.03,380
injurySignal5945.636.12,538
unevaluable eventSignal5539.531.02,033
renal failureSignal7430.324.72,080
stressSignal3828.721.2990
renal impairmentSignal3824.618.2840
emotional distressSignal4319.314.6732
toxicity to various agentsSignal4915.812.2670
anxietySignal5811.18.7529
hypotensionSignal349.26.7243
painSignal625.54.4230
drug ineffectiveSignal532.21.735

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.